Le Lézard
Classified in: Health, Science and technology
Subject: TRADE SHOWS/SEMINARS/WEBINARS

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil(TM), at Natural Products Expo West in Anaheim, CA - March 9-12, 2017


LAS VEGAS, NV--(Marketwired - February 28, 2017) - CV Sciences, Inc. (OTCBB: CVSI), leading supplier and manufacturer of hemp-derived CBD oil, announces that its industry dominating brand of hemp-derived CBD oil finished products, PlusCBD Oiltm will be exhibiting at Natural Products Expo West on March 9-12, in Anaheim, California. Produced by New Hope Network, Natural Products Expo West is one of the world's leading trade shows in the natural, organic and healthy products industry attracting over 77,000 industry professionals and 3,000 exhibits to the Anaheim Convention Center.

PlusCBD Oiltm, #1 brand of hemp-derived CBD products in the natural channel according to SPINS data, has achieved immense success since the launch of its brand of dietary supplements in 2014. PlusCBD Oiltm will be the only hemp-derived CBD brand exhibiting at Expo West.

"As the preeminent leaders in hemp-derived CBD, we believe it is our obligation to create products that retailers can count on," stated Stuart Tomc, VP of Human Nutrition and spokesperson at CV Sciences. "PlusCBD Oiltm has been driving the growth of this newly emerging category due to the consistency, efficacy, and safety profile of our products. We are pleased to report that PlusCBD Oiltm is now available in over 1000 health food stores and counting, and we truly have our retailer partners to thank for joining the CBD Evolution -- many of whom have been with us since our first Expo West two years ago."

TWO BOOTH LOCATIONS: CV Sciences will be hosting two booths at Expo West this year. Attendees are invited to visit Booth #H301 in the Hot Products section from Thursday, March 9th through Saturday, March 11th and Booth #1320 in Supplements section from Friday, March 10th through Sunday, March 12th where CV Sciences will be featuring PlusCBD Oiltm bulk and finished products.

EXHIBITOR-SPONSORED PRESENTATION: Join the CV Sciences team for an interactive presentation, "The Cannabis Disruption: Bringing Hemp Back," on Friday, March 10th, 2017 at 3:30pm in the Marriott, Marquis Ballroom Northeast. Presenters Stuart Tomc and Josh Hendrix will cover the state of hemp-derived CBD in the United States marketplace, the importance of proper research steps in order to impact the future of hemp agriculture, and how CV Sciences demonstrates Full Traceability - From Seed to Shelftm.

NEW PRODUCTS: The PlusCBD Oiltm line is growing! CV Sciences is proud to announce the launch of the PlusCBD Oiltm Raw Line, featuring PlusCBD Oiltm Softgels made with full plant raw CO2-extracted hemp extract. Offered in 30 count blister packs and 60 count bottles, PlusCBD Oiltm Raw Softgels provide the fullest spectrum of naturally occurring hemp co-factors. As with all PlusCBD Oiltm products, these new items are non-GMO, gluten free, and 100% vegetarian/vegan friendly.

SHOW SPECIALS: CV Sciences offers exclusive trade show discounts and show specials to retailers placing orders at the show. Discounts will be honored through the week following Expo West. Please see a CV Sciences associate for more information.

ABOUT CV SCIENCES: CV Sciences, Inc. (OTCBB: CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oiltm brand, the leading hemp-derived CBD product line in the United States. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com.


These press releases may also interest you

at 07:30
Carisma Therapeutics Inc.  ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced new data demonstrating preclinical proof of concept using...

at 07:30
NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer's Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of...

at 07:30
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced today that it has...

at 07:30
? Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into 2028 and 2029, Well Beyond Expected Data Readouts and Potential Approvals from the Company's...

at 07:28
Naborforce, an age-tech company whose platform provides on-demand everyday assistance to seniors, today announced that it has expanded its nationally renowned services to Greensboro, Winston-Salem, High Point, and the Greater Wilmington Region. The...

at 07:17
Logical Biological, a...



News published on and distributed by: